Who are the Institutional Holders in Conformis Inc. (CFMS)?

68 institutions hold shares in Conformis Inc. (CFMS), with 6.11M shares held by insiders accounting for 7.11% while institutional investors hold 32.98% of the company’s shares. The shares outstanding are 95.55M, and float is at 74.04M with Short Float at 1.21%. Institutions hold 30.64% of the Float.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is Armistice Capital, LLC with over 7.48 million shares valued at $6.26 million. The investor’s holdings represent 8.70% of the CFMS Shares outstanding. As of Dec 30, 2020, the second largest holder is Renaissance Technologies, LLC with 5.88 million shares valued at $3.88 million to account for 6.85% of the shares outstanding. The other top investors are Archon Capital Management LLC which holds 3.86 million shares representing 4.49% and valued at over $3.23 million, while Vanguard Group, Inc. (The) holds 3.55% of the shares totaling 3.05 million with a market value of $2.56 million.

Conformis Inc. (NASDAQ: CFMS) is 62.12% higher on its value in year-to-date trading and has touched a low of $0.50 and a high of $1.49 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CFMS stock was last observed hovering at around $1.12 in the last trading session, with the day’s loss setting it -0.05% off its average median price target of $2.00 for the next 12 months. It is also 64.33% off the consensus price target high of $3.00 offered by 4 analysts, but current levels are 46.5% higher than the price target low of $2.00 for the same period.

Currently trading at $1.07, the stock is -12.26% and 12.24% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.43 million and changing -4.46% at the moment leaves the stock 29.21% off its SMA200. CFMS registered -2.73% loss for a year compared to 6-month gain of 63.36%. The firm has a 50-day simple moving average (SMA 50) of $1.1088 and a 200-day simple moving average (SMA200) of $0.8081.

The stock witnessed a -13.01% loss in the last 1 month and extending the period to 3 months gives it a 64.51%, and is -20.15% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.01% over the week and 13.23% over the month.

Conformis Inc. (CFMS) has around 262 employees, a market worth around $197.70M and $72.00M in sales. Profit margin for the company is -32.10%. Distance from 52-week low is 113.87% and -28.19% from its 52-week high. The company has generated returns on investments over the last 12 months (-70.10%).

Conformis Inc. (CFMS) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Conformis Inc. (CFMS) is a “Overweight”. 4 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.

Conformis Inc. is expected to release its quarterly report on 05/13/2021 and quarterly earnings per share for the current quarter are estimated at -$0.1 with sales reaching $17.68M over the same period.The EPS is expected to grow by 39.70% this year, but quarterly earnings will post -9.50% year-over-year. Quarterly sales are estimated to shrink -11.10% in year-over-year returns.

Conformis Inc. (CFMS) Insider Activity

A total of 6 insider transactions have happened at Conformis Inc. (CFMS) in the last six months, with sales accounting for 6 and purchases happening 0 times. The most recent transaction is an insider sale by HOWE ROBERT S, the company’s CFO & TREASURER. SEC filings show that HOWE ROBERT S sold 11,206 shares of the company’s common stock on Feb 17 at a price of $1.19 per share for a total of $13335.0. Following the sale, the insider now owns 0.21 million shares.

Conformis Inc. disclosed in a document filed with the SEC on Jan 05 that Augusti Mark A (President & CEO) sold a total of 32,260 shares of the company’s common stock. The trade occurred on Jan 05 and was made at $0.75 per share for $24127.0. Following the transaction, the insider now directly holds 2.25 million shares of the CFMS stock.

Still, SEC filings show that on Jan 04, Augusti Mark A (President & CEO) disposed off 61,025 shares at an average price of $0.64 for $39160.0. The insider now directly holds 2,280,345 shares of Conformis Inc. (CFMS).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Conformis Inc. (CFMS): Who are the competitors?

The company’s main competitors (and peers) include DexCom Inc. (DXCM) that is trading 38.49% up over the past 12 months. Masimo Corporation (MASI) is 42.65% up on the 1-year trading charts. Short interest in the company’s stock has fallen -459.6% from the last report on Dec 30, 2020 to stand at a total of 5.0 million short shares sold with a short interest ratio of 0.21.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free